Impact of Preoperative Cholangitis on Short-term Outcomes Among Patients Undergoing Liver Resection.
Cholangitis
Liver resection
Outcomes
Preoperative
Journal
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: United States
ID NLM: 9706084
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
16
08
2019
accepted:
14
10
2019
pubmed:
21
11
2019
medline:
15
4
2021
entrez:
21
11
2019
Statut:
ppublish
Résumé
The impact of preoperative cholangitis (PC) on perioperative outcomes among patients undergoing liver resection remains poorly defined. We sought to characterize the prevalence of PC among patients undergoing hepatectomy and define the impact of PC on postoperative outcomes. Patients who underwent liver resection between 2013 and 2015 were identified using the Center for Medicare Services (CMS) 100% Limited Data Set (LDS) Standard Analytic Files (SAFs). Short-term outcomes after liver resection, stratified by the presence of PC, were examined. Subgroup analyses were performed to evaluate the relationship between the timing of liver resection relative to PC. Among 7392 patients undergoing liver resection, 251 patients (3.4%) experienced PC. Patients with PC were more likely to be male (59.0% vs. 50.6%) and to have a benign diagnosis (34.3% vs. 19.8%) compared with patients without PC (both p<0.05). On multivariable analysis, PC was associated with increased odds of experiencing a complication (OR 1.54, 95%CI 1.17-2.03), extended LOS (OR 2.60, 95%CI 1.99-3.39), 90-day mortality (OR 2.31, 95%CI 1.64-3.26), and higher Medicare expenditures (OR 3.32, 95%CI 2.55-4.32). Among patients with PC, requirement of both endoscopic and percutaneous biliary drainage (OR 5.16, 95%CI 1.36-9.61), as well as liver resection < 2 weeks after PC (OR 2.92, 95%CI 1.13-7.57) were associated with higher odds of 90-day mortality. Approximately 1 in 30 Medicare beneficiaries undergoing liver resection had a history of PC. PC was associated with an increased risk of adverse short-term outcomes and higher healthcare expenditures among patients undergoing hepatectomy.
Sections du résumé
BACKGROUND
The impact of preoperative cholangitis (PC) on perioperative outcomes among patients undergoing liver resection remains poorly defined. We sought to characterize the prevalence of PC among patients undergoing hepatectomy and define the impact of PC on postoperative outcomes.
METHODS
Patients who underwent liver resection between 2013 and 2015 were identified using the Center for Medicare Services (CMS) 100% Limited Data Set (LDS) Standard Analytic Files (SAFs). Short-term outcomes after liver resection, stratified by the presence of PC, were examined. Subgroup analyses were performed to evaluate the relationship between the timing of liver resection relative to PC.
RESULTS
Among 7392 patients undergoing liver resection, 251 patients (3.4%) experienced PC. Patients with PC were more likely to be male (59.0% vs. 50.6%) and to have a benign diagnosis (34.3% vs. 19.8%) compared with patients without PC (both p<0.05). On multivariable analysis, PC was associated with increased odds of experiencing a complication (OR 1.54, 95%CI 1.17-2.03), extended LOS (OR 2.60, 95%CI 1.99-3.39), 90-day mortality (OR 2.31, 95%CI 1.64-3.26), and higher Medicare expenditures (OR 3.32, 95%CI 2.55-4.32). Among patients with PC, requirement of both endoscopic and percutaneous biliary drainage (OR 5.16, 95%CI 1.36-9.61), as well as liver resection < 2 weeks after PC (OR 2.92, 95%CI 1.13-7.57) were associated with higher odds of 90-day mortality.
CONCLUSION
Approximately 1 in 30 Medicare beneficiaries undergoing liver resection had a history of PC. PC was associated with an increased risk of adverse short-term outcomes and higher healthcare expenditures among patients undergoing hepatectomy.
Identifiants
pubmed: 31745898
doi: 10.1007/s11605-019-04430-7
pii: 10.1007/s11605-019-04430-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2508-2516Références
Newhook TE, LaPar DJ, Lindberg JM, Bauer TW, Adams RB, Zaydfudim VM. Morbidity and mortality of hepatectomy for benign liver tumors. American journal of surgery. 2016;211(1):102–8. doi: https://doi.org/10.1016/j.amjsurg.2015.06.010 .
doi: 10.1016/j.amjsurg.2015.06.010
Cheung TT, Dai WC, Tsang SH, Chan AC, Chok KS, Chan SC et al. Pure Laparoscopic Hepatectomy Versus Open Hepatectomy for Hepatocellular Carcinoma in 110 Patients With Liver Cirrhosis: A Propensity Analysis at a Single Center. Annals of surgery. 2016;264(4):612–20. doi: https://doi.org/10.1097/sla.0000000000001848 .
doi: 10.1097/sla.0000000000001848
Wu L, Tsilimigras DI, Paredes AZ, Mehta R, Hyer JM, Merath K et al. Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival. World journal of surgery. 2019. doi: https://doi.org/10.1007/s00268-019-04966-4 .
Kimura Y, Takada T, Strasberg SM, Pitt HA, Gouma DJ, Garden OJ et al. TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis. Journal of hepato-biliary-pancreatic sciences. 2013;20(1):8–23. doi: https://doi.org/10.1007/s00534-012-0564-0 .
doi: 10.1007/s00534-012-0564-0
Gigot JF, Leese T, Dereme T, Coutinho J, Castaing D, Bismuth H. Acute cholangitis. Multivariate analysis of risk factors. Annals of surgery. 1989;209(4):435–8.
doi: 10.1097/00000658-198904000-00008
Liu TJ. Acute biliary septic shock. HPB surgery : a world journal of hepatic, pancreatic and biliary surgery. 1990;2(3):177–83.
doi: 10.1155/1990/71059
Lai EC, Tam PC, Paterson IA, Ng MM, Fan ST, Choi TK et al. Emergency surgery for severe acute cholangitis. The high-risk patients. Annals of surgery. 1990;211(1):55–9.
doi: 10.1097/00000658-199001000-00009
Sakata J, Shirai Y, Tsuchiya Y, Wakai T, Nomura T, Hatakeyama K. Preoperative cholangitis independently increases in-hospital mortality after combined major hepatic and bile duct resection for hilar cholangiocarcinoma. Langenbeck’s Archives of Surgery. 2009;394(6):1065–72. doi: https://doi.org/10.1007/s00423-009-0464-1 .
doi: 10.1007/s00423-009-0464-1
Kanai M, Nimura Y, Kamiya J, Kondo S, Nagino M, Miyachi M et al. Preoperative intrahepatic segmental cholangitis in patients with advanced carcinoma involving the hepatic hilus. Surgery. 1996;119(5):498–504. doi: https://doi.org/10.1016/S0039-6060(96)80257-1 .
doi: 10.1016/S0039-6060(96)80257-1
Ribero D, Zimmitti G, Aloia TA, Shindoh J, Fabio F, Amisano M et al. Preoperative Cholangitis and Future Liver Remnant Volume Determine the Risk of Liver Failure in Patients Undergoing Resection for Hilar Cholangiocarcinoma. Journal of the American College of Surgeons. 2016;223(1):87–97. doi: https://doi.org/10.1016/j.jamcollsurg.2016.01.060 .
doi: 10.1016/j.jamcollsurg.2016.01.060
Mulki R, Shah R, Qayed E. Early vs late endoscopic retrograde cholangiopancreatography in patients with acute cholangitis: A nationwide analysis. World J Gastrointest Endosc. 2019;11(1):41–53. doi: https://doi.org/10.4253/wjge.v11.i1.41 .
doi: 10.4253/wjge.v11.i1.41
Huang RJ, Barakat MT, Girotra M, Banerjee S. Practice Patterns for Cholecystectomy After Endoscopic Retrograde Cholangiopancreatography for Patients With Choledocholithiasis. Gastroenterology. 2017;153(3):762–71 e2. doi: https://doi.org/10.1053/j.gastro.2017.05.048 .
doi: 10.1053/j.gastro.2017.05.048
McNabb-Baltar J, Trinh QD, Barkun AN. Disparities in outcomes following admission for cholangitis. PLoS One. 2013;8(3):e59487. doi: https://doi.org/10.1371/journal.pone.0059487 .
doi: 10.1371/journal.pone.0059487
Ali N, O’Rourke C, El-Hayek K, Chalikonda S, Jeyarajah DR, Walsh RM. Estimating the need for hepato-pancreatico-biliary surgeons in the USA. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2015;17(4):352–6. doi: https://doi.org/10.1111/hpb.12370 .
doi: 10.1111/hpb.12370
Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical care. 2005;43(11):1130–9.
doi: 10.1097/01.mlr.0000182534.19832.83
Osborne NH, Nicholas LH, Ryan AM, Thumma JR, Dimick JB. Association of hospital participation in a quality reporting program with surgical outcomes and expenditures for Medicare beneficiaries. Jama. 2015;313(5):496–504. doi: https://doi.org/10.1001/jama.2015.25 .
doi: 10.1001/jama.2015.25
Iezzoni LI, Daley J, Heeren T, Foley SM, Hughes JS, Fisher ES et al. Using administrative data to screen hospitals for high complication rates. Inquiry : a journal of medical care organization, provision and financing. 1994;31(1):40–55.
Ueno M, Hayami S, Tani M, Kawai M, Hirono S, Yamaue H. Recent trends in hepatectomy for elderly patients with hepatocellular carcinoma. Surgery today. 2014;44(9):1651–9. doi: https://doi.org/10.1007/s00595-013-0739-6 .
doi: 10.1007/s00595-013-0739-6
Vitale A, Spolverato G, Bagante F, Gani F, Popescu I, Marques HP et al. A multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma. Journal of Surgical Oncology. 2016;113(4):420–6. doi: https://doi.org/10.1002/jso.24148 .
doi: 10.1002/jso.24148
Petrowsky H, Clavien PA. Should we deny surgery for malignant hepato-pancreatico-biliary tumors to elderly patients? World journal of surgery. 2005;29(9):1093–100. doi: https://doi.org/10.1007/s00268-005-1130-6 .
doi: 10.1007/s00268-005-1130-6
Sahara K, Paredes AZ, Merath K, Tsilimigras DI, Bagante F, Ratti F et al. Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2019. doi: https://doi.org/10.1007/s11605-019-04174-4 .
Sahara K, Paredes AZ, Tsilimigras DI, Hyer JM, Merath K, Wu L et al. Impact of Liver Cirrhosis on Perioperative Outcomes Among Elderly Patients Undergoing Hepatectomy: the Effect of Minimally Invasive Surgery. Journal of Gastrointestinal Surgery. 2019. doi: https://doi.org/10.1007/s11605-019-04117-z .
Hirano S, Kondo S, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K et al. Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. Journal of hepato-biliary-pancreatic sciences. 2010;17(4):455–62. doi: https://doi.org/10.1007/s00534-009-0208-1 .
doi: 10.1007/s00534-009-0208-1
Kitahata Y, Kawai M, Tani M, Hirono S, Okada K-i, Miyazawa M et al. Preoperative cholangitis during biliary drainage increases the incidence of postoperative severe complications after pancreaticoduodenectomy. The American Journal of Surgery. 2014;208(1):1–10. doi: https://doi.org/10.1016/j.amjsurg.2013.10.021 .
doi: 10.1016/j.amjsurg.2013.10.021
Yokoyama Y, Ebata T, Igami T, Sugawara G, Mizuno T, Nagino M. The adverse effects of preoperative cholangitis on the outcome of portal vein embolization and subsequent major hepatectomies. Surgery. 2014;156(5):1190–6. doi: https://doi.org/10.1016/j.surg.2014.04.036 .
doi: 10.1016/j.surg.2014.04.036
Olthof PB, Wiggers JK, Groot Koerkamp B, Coelen RJ, Allen PJ, Besselink MG et al. Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization. Journal of the American College of Surgeons. 2017;225(3):387–94. doi: https://doi.org/10.1016/j.jamcollsurg.2017.06.007 .
doi: 10.1016/j.jamcollsurg.2017.06.007
Kaneko T, Imaizumi H, Kida M, Miyata E, Yamauchi H, Okuwaki K et al. Influence of cholangitis after preoperative endoscopic biliary drainage on postoperative pancreatic fistula in patients with middle and lower malignant biliary strictures. Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society. 2018;30(1):90–7. doi: https://doi.org/10.1111/den.12894 .
doi: 10.1111/den.12894
Wang Y, Fu W, Tang Z, Meng W, Zhou W, Li X. Effect of preoperative cholangitis on prognosis of patients with hilar cholangiocarcinoma: A systematic review and meta-analysis. Medicine. 2018;97(34):e12025. doi: https://doi.org/10.1097/md.0000000000012025 .
doi: 10.1097/md.0000000000012025
Kamiya S, Nagino M, Kanazawa H, Komatsu S, Mayumi T, Takagi K et al. The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microflora. Annals of surgery. 2004;239(4):510–7.
doi: 10.1097/01.sla.0000118594.23874.89
Gomi H, Solomkin JS, Schlossberg D, Okamoto K, Takada T, Strasberg SM et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. Journal of hepato-biliary-pancreatic sciences. 2018;25(1):3–16. doi: https://doi.org/10.1002/jhbp.518 .
doi: 10.1002/jhbp.518
Ozawa K, Yamaoka Y, Kitamura O, Nambu H, Kamiyama Y. Clinical application of cytochrome a(plus a3) assay of mitochondria from liver specimens: an aid in determining metabolic tolerance of liver remnant for hepatic resection. Annals of surgery. 1974;180(6):868–76.
doi: 10.1097/00000658-197412000-00013
Ramanathan R, Borrebach J, Tohme S, Tsung A. Preoperative Biliary Drainage Is Associated with Increased Complications After Liver Resection for Proximal Cholangiocarcinoma. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2018;22(11):1950–7. doi: https://doi.org/10.1007/s11605-018-3861-3 .
doi: 10.1007/s11605-018-3861-3
Miura F, Okamoto K, Takada T, Strasberg SM, Asbun HJ, Pitt HA et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. Journal of hepato-biliary-pancreatic sciences. 2018;25(1):31–40. doi: https://doi.org/10.1002/jhbp.509 .
doi: 10.1002/jhbp.509
Nimura Y. Preoperative biliary drainage before resection for cholangiocarcinoma (Pro). HPB. 2008;10(2):130–3. doi: https://doi.org/10.1080/13651820801992666 .
doi: 10.1080/13651820801992666
Coelen RJS, Roos E, Wiggers JK, Besselink MG, Buis CI, Busch ORC et al. Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial. The lancet Gastroenterology & hepatology. 2018;3(10):681–90. doi: https://doi.org/10.1016/s2468-1253(18)30234-6 .
doi: 10.1016/s2468-1253(18)30234-6